Michael Sherman
Vorsitzender bei CHIMERIX, INC.
Vermögen: 342 023 $ am 31.05.2024
Aktive Positionen von Michael Sherman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CHIMERIX, INC. | Vorsitzender | 01.08.2023 | - |
Direktor/Vorstandsmitglied | 08.04.2019 | 01.08.2023 | |
Vorstandsvorsitzender | 08.04.2019 | 01.08.2023 | |
Präsident | 08.04.2019 | 01.08.2023 | |
WEREWOLF THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 27.05.2021 | - |
Independent Dir/Board Member | 27.05.2021 | - | |
The Children's Museum of Indianapolis, Inc. | Direktor/Vorstandsmitglied | - | - |
Vorsitzender | 01.01.2012 | 01.12.2022 |
Karriereverlauf von Michael Sherman
Ehemalige bekannte Positionen von Michael Sherman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOSPECIFICS TECHNOLOGIES CORP. | Direktor/Vorstandsmitglied | 06.04.2020 | 02.12.2020 |
Independent Dir/Board Member | 06.04.2020 | 02.12.2020 | |
ENDOCYTE, INC. | Direktor/Vorstandsmitglied | 16.06.2016 | 21.12.2018 |
Vorstandsvorsitzender | 16.06.2016 | 21.12.2018 | |
Geschäftsführer | 16.06.2014 | 16.06.2016 | |
Finanzdirektor/CFO | 01.10.2006 | 21.02.2017 | |
Präsident | 16.06.2016 | 21.12.2018 | |
MEAD JOHNSON NUTRITION CO | Direktor/Vorstandsmitglied | 26.02.2015 | 15.06.2017 |
Independent Dir/Board Member | 26.02.2015 | 15.06.2017 | |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Finanzdirektor/CFO | 01.10.2006 | 01.10.2006 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Ausbildung von Michael Sherman
DePauw University | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 11 |
Operativ
Director/Board Member | 6 |
Independent Dir/Board Member | 3 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
CHIMERIX, INC. | Health Technology |
WEREWOLF THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
The Children's Museum of Indianapolis, Inc. | |
Mead Johnson Nutrition Co.
Mead Johnson Nutrition Co. Food: Meat/Fish/DairyConsumer Non-Durables Mead Johnson Nutrition Co. produces infant and children's nutrition products. The firm offers Enfamil brand. The firm's product portfolio includes: children nutrition, nutrition for infants, for the dietary management of protein allergies, nutrition for preterm, low birth weight babies, for expecting or breastfeeding moms. The company was founded by Edward Mead Johnson, Sr. in 1905 and is headquartered in Chicago, IL. | Consumer Non-Durables |
BioSpecifics Technologies Corp.
BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
- Börse
- Insiders
- Michael Sherman
- Erfahrung